secwatch / observer
8-K filed February 21, 2024, 6:59 PM ET ticker JAZZ CIK 0001232524
leadership confidence high sentiment neutral materiality 0.60

Jazz Pharmaceuticals names Philip Johnson as CFO, effective March 1, 2024

Jazz Pharmaceuticals plc

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Philip Johnson

Executive Vice President and Chief Financial Officer
JAZZ · Jazz Pharmaceuticals plc
Effective
2024-03-01
Filed
February 21, 2024, 6:59 PM ET
On February 21, 2024, Jazz Pharmaceuticals plc (the “Company”) announced the appointment of Philip Johnson as the Company’s Executive Vice President and Chief Financial Officer, effective as of March 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Philip Johnson was appointed as Executive Vice President and Chief Financial Officer at Jazz Pharmaceuticals plc.

Action
appointed
Role
Executive Vice President and Chief Financial Officer
Exact text from the filing
On February 21, 2024, Jazz Pharmaceuticals plc (the “Company”) announced the appointment of Philip Johnson as the Company’s Executive Vice President and Chief Financial Officer, effective as of March 1, 2024.
View on SEC.gov

Jazz Pharmaceuticals plc filing history →

Source: SEC EDGAR
accession 0001193125-24-040726
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.